Category Archives: Financial arrangements

How care is paid for

Counselling behavioural interventions for HIV, STI and viral hepatitis among key populations: A systematic review of effectiveness, values and preferences, and cost studies

2023

INTRODUCTION: Key populations (sex workers, men who have sex with men, people who inject drugs, people in prisons and other closed settings, and trans and gender diverse individuals) are disproportionately...

The effects of cash transfer programmes on HIV/AIDS prevention and care outcomes: A systematic review and meta-analysis of intervention studies

2023

Background: Poverty and social inequality are risk factors for poor health outcomes in patients with HIV/AIDS. In addition to eligibility, cash transfer programmes can be divided into two categories: those with...

Implementation and resource needs for long-acting PrEP in low- and middle-income countries: A scoping review

2023

INTRODUCTION: Several low- and middle-income countries (LMICs) are preparing to introduce long-acting pre-exposure prophylaxis (LAP). Amid multiple pre-exposure prophylaxis (PrEP) options and constrained funding, decision-makers could benefit from systematic implementation...

Cost-effectiveness of anti-retroviral adherence interventions for people living with HIV: A systematic review of decision analytical models

2023

BACKGROUND: Although safe and effective anti-retrovirals (ARVs) are readily available, non-adherence to ARVs is highly prevalent among people living with human immunodeficiency virus/acquired immunodeficiency syndrome (PLWHA). Different adherence-improving interventions have...

Modelling methods of economic evaluations of HIV testing strategies in sub-Saharan Africa: A systematic review

2023

BACKGROUND AND OBJECTIVE: Economic evaluations, a decision-support tool for policy makers, will be crucial in planning and tailoring HIV prevention and treatment strategies especially in the wake of stalled and...

Use of stated preference methods in HIV treatment and prevention research in the United States: A systematic review

2023

Stated preference (SP) methods are increasingly being applied to HIV-related research and continuously provide researchers with health utility scores of select healthcare products or services that populations consider important. Following...

Health economic analyses of latent tuberculosis infection screening and preventive treatment among people living with HIV in lower tuberculosis incidence settings: A systematic review

2023

Introduction: In lower tuberculosis (TB) incidence countries (<100 cases/100,000/year), screening and preventive treatment (PT) for latent TB infection (LTBI) among people living with HIV (PLWH) is often recommended, yet guidelines...

Are intersectoral costs considered in economic evaluations of interventions relating to sexually transmitted infections (STIs)? A systematic review

2022

BACKGROUND/OBJECTIVE: Sexually transmitted infections (STIs) not only have an impact on the health sector but also the private resources of those affected, their families and other sectors of society (i.e....

Cost-effective strategies of testing for HIV and sexually transmitted infections (STIs)

2022

Rates of chlamydia, gonorrhea, and infectious syphilis have risen in Canada from 2015 to 2019. An observed decrease in HIV cases has been detected recently, however a reduction in testing...

Activity-based costing for HIV, primary care and nutrition services in low- and middle-income countries: A systematic literature review and synthesis

2022

BACKGROUND: This study is a systematic literature review of HIV, nutrition, and primary care activity-based costing (ABC) studies conducted in low- and middle-income countries. ABC studies are critical for understanding...

Mathematical models for evaluating effectiveness and cost-effectiveness of cervical cancer control policies in populations including women living with human immunodeficiency virus: A scoping review

2022

Objectives: Mathematical modeling is increasingly used to inform cervical cancer control policies, and model-based evaluations of such policies in women living with human immunodeficiency virus (HIV) are an emerging research area....

Economic benefits of the United States’ AIDS drug assistance program: A systematic review of cost analyses to guide research and policy priorities

2022

As part of the Ryan White HIV/AIDs Program, the federally-funded, state-administered AIDS Drug Assistance Program (ADAP) provides prescription drug medications, including antiretroviral therapy, for people with HIV (PWH) who are...

Email 1 selected articles

Email 1 selected articles

Error! The email wasn't sent. Please try again.

Your email has been sent!